The timing has been terrible. If OCC had given ATI interim results last June (2020) how different things might have been. To be frank, there are other bio-techs I have small positions in that I've mostly built recently, that have done far worse (CYP, PAR, PNV...MSB I had a moderate position on this year and has eroded most of my 2021 profits). You are invested in a small cap, negative free cash flow stock. It was always a risk. NOw on the verge of announcements is not the time to sell.
Ann: OCC Secures Patents for Suture-Less Repair of Soft Tissue, page-28
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3807 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 3666 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |